HIV Viral Load
HIV viral load measures the amount of HIV RNA in the blood, indicating the level of virus present and the effectiveness of antiretroviral therapy.
HIV viral load quantifies the amount of HIV RNA in the blood to monitor infection and treatment efficacy.
Key facts at a glance
- Units
- copies/mL
- Clinical utility
- monitoring
- Result kind
- quantitative
- FDA-cleared
- Roche HIV Viral Load, Abbott HIV Viral Load, Siemens HIV Viral Load
HIV viral load is a critical biomarker used to assess the level of HIV infection in a patient's bloodstream. It measures the number of copies of HIV RNA per milliliter of blood.
This biomarker is essential for monitoring the effectiveness of antiretroviral therapy (ART). A decreasing viral load typically indicates that the treatment is working, while an increasing or consistently high viral load may suggest treatment failure.
The target for HIV viral load in treated patients is usually to maintain it below 20 copies/mL. Regular monitoring helps in adjusting treatment strategies and preventing disease progression.
Frequently asked questions
How often should HIV viral load be tested?
What factors can affect HIV viral load results?
Sources
- 1
- 2CDC HIV Viral LoadSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy